During the opening ceremony of the BIO Asia-Taiwan Exhibition yesterday in Taipei, President Tsai Ing-wen (蔡英文) expressed the hope that advancements in Taiwan’s biotechnology industry would usher in major business opportunities from abroad, allowing the sector to reach NT$1 trillion (US$339.50 billion) in annual production.
Despite COVID-19, the annual biotech trade show attracted pharmaceutical and medical device companies from more than 500 nations, including the US, the UK, Australia, Switzerland and Malaysia.
The five-day exhibition is the first in-person international biotechnology trade show in Asia since the outbreak of COVID-19.
Photo: Chien Jung-fong, Taipei Times
Speaking at the opening ceremony, Tsai said that biotechnology is a crucial part of the “five plus two” innovative industries plan that she introduced during her first term, adding that she hopes the exhibition would be a platform for the nation to demonstrate innovativeness and accelerate the development of its biotech sector.
The nation would deregulate relevant laws to expedite the growth of the sector, she said.
The “five plus two” innovative industries plan refers to an initiative to develop an Asian equivalent of the US’ Silicon Valley, including biotech, green energy, industry 4.0, robotics, defense and aviation, as well as innovative agriculture and a circular economy.
Taiwan’s biomedical industry grew by 8.7 percent in annual revenue last year, a record high over the past few years, with the amount of capital invested reaching NT$55.1 billion, Tsai said, adding that digital medicine and precision medicine, two sectors that have shown great potential in recent years, are expected to grow significantly.
Cell therapy, regenerative medicine and genetic testing combined with big data analysis are also areas that have progressed a lot, while innovative medical devices, including nanomedical technology, are expected to receive more attention, she said.
New medicine development has also had breakthroughs, Tsai said, citing a licensing agreement signed in April by Taiwan’s Oneness Biotech Co Ltd and the Denmark-based Leo Pharma, a global leader in medical dermatology.
The agreement was signed to facilitate the development and introduction to the market of FB825, a drug candidate for novel atopic dermatitis and asthma, with an upfront payment to Oneness totaling US$530 million, the highest a Taiwanese company has ever received in such a deal.
Meanwhile, the National Biotechnology Research Park in collaboration with several multi-national pharmaceutical companies, accelerators and venture capital firms yesterday opened an accelerator hub for biomedical start-ups.
Speaking at the inauguration ceremony of the hub, former vice president Chen Chien-jen (陳建仁) said that the new facilities provide one-stop services to cultivate biomedical start-ups and has the potential to become the biggest accelerator hub in the field of biomedicine in the Asia-Pacific region.
The occupancy rate of biomedical companies at the park is 60 percent and the number is expected to reach 80 percent by the end of the year, Chen said, adding that growth at such a rate would be “beyond my imagination.”
Additional reporting by Chien Hui-ju
A total of 400 foreign “high- level” professionals have been naturalized as Republic of China (Taiwan) citizens over the past decade as the government has eased nationality rules to attract talent from a wider range of fields, the Ministry of the Interior said yesterday. The 400th high-level professional, who works in the electronics industry, was approved for ROC citizenship on Aug. 26, the MOI said. The MOI quoted the newly naturalized citizen as saying that Taiwan is a leader in fields such as semiconductors, electronics manufacturing, artificial intelligence development and energy technology. He also said
OCT. 31: The antiviral drugs Tamiflu and Eraflu have been distributed to about 4,000 medical facilities nationwide for people in seven groups who develop flu-like symptoms As the domestic influenza epidemic enters its peak season and continues to escalate, the Centers for Disease Control (CDC) yesterday announced that publicly funded influenza antiviral drugs for seven eligible groups have been extended to Oct. 31, allowing those who develop flu-like symptoms to receive the medication without undergoing a rapid influenza test. The CDC has extended the expanded use of flu antiviral drugs to seven groups: healthcare and influenza-prevention personnel; residents and staff at nursing homes, long-term care facilities and similar institutions; kindergarten and daycare workers and home-based caregivers; students from kindergarten through high school, vocational high school and the
A Chinese military drone was spotted conducting reconnaissance off Taitung County as President William Lai (賴清德) visited Pingtung County this morning to inspect a drill of the armed forces’ precision-strike capabilities, prompting the military to closely monitor its actions. Today was the final day of a three-day military exercise at Jioupeng Base (九鵬基地) to test the joint combat capabilities of the armed forces and coast guard. The exercise began on Wednesday simulating air defense interception and yesterday tested long-range strike capabilities and new air defense weapons. This morning, the military conducted a final exercise involving air defense, anti-ship and drone operations. Military sources said
China has warned that it could cancel a planned US-China leaders’ summit if Washington approves new arms sales to Taiwan, a Japanese media outlet quoted sources as saying yesterday. US President Donald Trump, “apparently eager to showcase some diplomatic achievements ahead of November’s midterm congressional elections, places great importance on holding the summit with Chinese President Xi Jinping (習近平),” Japan’s Kyodo News reported. “While preparing for Xi’s upcoming trip, China has restated its position that the Taiwan issue is a ‘red line’ in bilateral relations,” the report said. The report said that when Xi met with Trump in Beijing in May, Xi said
RSS